Disease: Dystrophic epidermolysis bullosa
- [Translated article] Successful Control of Recalcitrant Pruritus in Epidermolysis Bullosa Pruriginosa With Dupilumab
- "Quality of Life in Epidermolysis Bullosa" and "Epidermolysis Bullosa Burden of Disease": Italian translation, cultural adaptation, and pilot testing of two disease-specific questionnaires
- A case of adult-onset localized recessive dystrophic epidermolysis bullosa, harboring the novel COL7A1 mutation p.G2754E and the previously reported mutation p.R1763
- A case of dystrophic epidermolysis bullosa with a rare COL7A1 variant
- A case of intermediate recessive dystrophic epidermolysis bullosa with a novel COL7A1 mutation
- A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab
- A case report of jejunum transplantation in the treatment of severe cervical esophageal stricture in patients with dystrophic epidermolysis bullosa
- A short RNA molecule and tumour aggressiveness in people with epidermolysis bullosa
- Accelerated Aging and Microsatellite Instability in Recessive Dystrophic Epidermolysis Bullosa-Associated Cutaneous Squamous Cell Carcinoma
- Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy
- Advantages of whole-exome sequencing over immunomapping in 67 Brazilian patients with epidermolysis bullosa
- An unusual cause of inguinal ulceration - dystrophic epidermolysis bullosa
- Antiviral drugs prolong survival in murine recessive dystrophic epidermolysis bullosa
- Attenuated Replication-Competent Herpes Simplex Virus Expressing an ECM-Modifying Transgene Hyaluronan Synthase 2 of Naked Mole Rat in Oncolytic Gene Therapy
- Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critical appraisal
- Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper
- Beyond the Surface: A Narrative Review Examining the Systemic Impacts of Recessive Dystrophic Epidermolysis Bullosa
- Birch Bark Extract: A Review in Epidermolysis Bullosa
- Bone marrow transplantation and bone marrow-derived mesenchymal stem cell therapy in epidermolysis bullosa: A systematic review
- Clinical and allelic heterogeneity in dystrophic epidermolysis bullosa- lessons from an Indian cohort
- Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa
- Clinical-grade human skin-derived ABCB5+ mesenchymal stromal cells exert anti-apoptotic and anti-inflammatory effects <em>in vitro</em> and modulate mRNA expression in a cisplatin-induced kidney injury murine model
- Comprehensive orthodontic treatment using miniscrews and digital rehabilitation in a patient with severe recessive dystrophic epidermolysis bullosa
- Congenital localized absence of skin (Bart syndrome) in a patient with dominant dystrophic epidermolysis bullosa
- Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782-788/1562]
- Costs of UK community care for individuals with recessive dystrophic epidermolysis bullosa: Findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study
- CRISPR-Cas9-based non-viral gene editing therapy for topical treatment of recessive dystrophic epidermolysis bullosa
- CRISPR/Cas9-Mediated Generation of <em>COL7A1</em>-Deficient Keratinocyte Model of Recessive Dystrophic Epidermolysis Bullosa
- CRISPR/Cas9-Mediated Generation of COL7A1-Deficient Keratinocyte Model of Recessive Dystrophic Epidermolysis Bullosa
- Current Treatment Landscape for Dystrophic Epidermolysis Bullosa: From Surgical Management to Emerging Gene Therapies and Novel Skin Grafts
- Cutaneous squamous cell carcinomas in EBDR: how can they be detected?
- Cutaneous squamous cell carcinomas: a complication of severe forms of hereditary epidermolysis bullosa
- Cyclization-enhanced poly(β-amino ester)s vectors for efficient CRISPR gene editing therapy
- Development of a nutritionally balanced, melt-in-the-mouth chocolate for patients with epidermolysis bullosa
- Dipeptidyl peptidase-4-mediated fibronectin processing evokes a pro-fibrotic extracellular matrix
- Dipeptidyl Peptidase-4-Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix
- Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin
- Dupilumab in the treatment of dystrophic epidermolysis bullosa: off-label use in a pediatric patient
- Dystrophic epidermolysis with dilation of esophageal stricture: A case report
- Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series
- Elevated expression of interleukin-6 (IL-6) and serum amyloid A (SAA) in the skin and the serum of recessive dystrophic epidermolysis bullosa: Skin as a possible source of IL-6 through Toll-like receptor ligands and SAA
- Epidermal or dermal collagen VII is sufficient for skin integrity - insights to anchoring fibril homeostasis
- Epidermal or Dermal Collagen VII Is Sufficient for Skin Integrity: Insights to Anchoring Fibril Homeostasis
- Epidermolysis Bullosa
- Epidermolysis Bullosa Acquisita
- Epidermolysis Bullosa Dystrophica Inversa: Case Report of a Novel Genetic Mutation, Involving a Rare Genodermatoses
- Epidermolysis bullosa pruriginosa: A case report of two first cousins
- Epidermolysis Bullosa-A Kindler Syndrome Case Report and Short Literature Review
- Epidermolysis Bullosa: Practical Clinical Tips From the Field
- Epidermolysis Bullosa: Two rare case reports of COL7A1 and EBS-GEN SEV KRT14 variants with review of literature
- Epidermolysis-Bullosa-Associated Squamous Cell Carcinomas Support an Immunosuppressive Tumor Microenvironment: Prospects for Immunotherapy
- Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa
- Evaluation of Clinical and Oral Findings in Patients with Epidermolysis bullosa
- Gamma-secretase inhibitors down-regulate the pro-fibrotic Notch signaling pathway in recessive dystrophic epidermolysis bullosa
- Gamma-Secretase Inhibitors Downregulate the Profibrotic NOTCH Signaling Pathway in Recessive Dystrophic Epidermolysis Bullosa
- Genetic diagnosis of a rare COL7A1 variant causing dystrophic epidermolysis bullosa pruriginosa through whole-exome sequencing
- Genetic diagnosis of a rare COL7A1 variant causing dystrophic epidermolysis bullosa pruriginosa through whole‑exome sequencing
- Gluten-sensitive enteropathy in recessive dystrophic epidermolysis bullosa
- Gross motor development in children with epidermolysis bullosa
- Health-related quality of life and clinical severity in people with epidermolysis bullosa - A proposal for assessing nutritional compromise by body mass index (Birmingham Epidermolysis Bullosa Severity Score)
- Hereditary epidermolysis bullosa: clinical-epidemiological profile of 278 patients at a tertiary hospital in Sao Paulo, Brazil
- Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)
- Highly Efficient Ex Vivo Correction of COL7A1 through Ribonucleoprotein-Based CRISPR/Cas9 and Homology-Directed Repair to Treat Recessive Dystrophic Epidermolysis Bullosa
- Highly efficient ex-vivo correction of COL7A1 through RNP-based CRISPR/Cas9 and Homology-Directed Repair to treat recessive dystrophic epidermolysis bullosa
- Identification of a novel COL7A1 variant associated with dystrophic epidermolysis bullosa pruriginosa responding effectively to dupilumab
- IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study
- Induced pluripotent stem cell (iPSC) line MLi005-A derived from a patient with dominant dystrophic epidermolysis bullosa (DDEB)
- Inflammation-mediated fibroblast activation and immune dysregulation in collagen VII-deficient skin
- Intravenous gentamicin therapy induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients: An open label clinical trial
- Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study
- Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro
- Management of acute sloughing of the esophageal lining in patients with dystrophic epidermolysis bullosa-A series of six pediatric patients
- Measuring the impact of pruritus in patients with epidermolysis bullosa: evaluation with an itch-specific instrument
- Mechanism underlying pruritus in recessive dystrophic epidermolysis bullosa: Role of interleukin-31 from mast cells and macrophages
- Metformin shows anti-neoplastic properties by inhibition of oxidative phosphorylation and glycolysis in epidermolysis bullosa-associated aggressive cutaneous squamous cell carcinoma
- Methods for Decreasing Preweaning Mortality in a Fragile Mouse Model of Hypomorphic Collagen VII Deficiency
- MicroRNA-200b-mediated reversion of a spectrum of epithelial-to-mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
- miR-200b-mediated reversion of a spectrum of epithelial to mesenchymal transition states in recessive dystrophic epidermolysis bullosa squamous cell carcinomas
- Misdiagnosis in Epidermolysis Bullosa: Yet Another Burden on Patients and their Families
- Missense Variant c.3301C>T (p.R1101W) in von Willebrand Factor A Sequence in a Patient with Recessive Dystrophic Epidermolysis Bullosa Pruriginosa with Compound Heterozygous <em>COL7A1</em> Variants
- Missense Variant c.3301C>T (p.R1101W) in von Willebrand Factor A Sequence in a Patient with Recessive Dystrophic Epidermolysis Bullosa Pruriginosa with Compound Heterozygous COL7A1 Variants
- Novel compound heterozygous mutations of the COL7A1 gene in a Chinese patient with recessive dystrophic epidermolysis bullosa pruriginosa and digestive symptoms successfully treated with tofacitinib
- Ocular Gene Therapy in a Patient with Dystrophic Epidermolysis Bullosa
- Oleogel-S10 in Dystrophic Epidermolysis Bullosa: A Case Series Evaluating the Impact on Wound Burden Over Two Years
- Oral prosthetic rehabilitation in patients with Epidermolysis Bullosa Hereditaria: a systematic review
- Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study
- Practical Tips on Epidermolysis Bullosa for Caregivers: Part 2
- Pruritus Anesis in Dystrophic Epidermolysis Bullosa Pruriginosa with Dupilumab
- Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy
- Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
- Self-improving dystrophic epidermolysis bullosa with a novel heterozygous missense variant in the COL7A1 gene in a Taiwanese family
- Simple and affordable soft brace application in dystrophic epidermolysis bullosa patients
- Skin Allograft after Bone Marrow Transplantation of Patient with Recessive Dystrophic Epidermolysis Bullosa
- Splicing Modulation via Antisense Oligonucleotides in Recessive Dystrophic Epidermolysis Bullosa
- Successful treatment of multicentric Castleman's disease associated with dystrophic epidermolysis bullosa using anti-interleukin-6 receptor antibody
- Temporal Changes in the Skin Microbiome of Epidermolysis Bullosa Patients following the Application of Wound Dressings
- Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: a case-control study
- The novel application of syringe needle in recessive dystrophic epidermolysis bullosa syndactyly release surgery
- Topical Gene Therapy Restores Vision in Ocular Dystrophic Epidermolysis Bullosa
- Why are squamous cancers so aggressive in recessive dystrophic epidermolysis bullosa? Can we find new therapeutic approaches?